Zhifei Biological: Adsorbed Tetanus Vaccine Enters Phase I/III Clinical Trials

On March 26, People’s Financial News reported that Zhifei Biological Products Co., Ltd. (300122) announced on March 26 that its wholly-owned subsidiary, Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd., has commenced Phase I/III clinical trials for its adsorbed tetanus vaccine in Chongqing.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin